NCT05186402

Brief Summary

This is a retrospective study extending over a period of three years concerning patients with gastric adenocarcinoma hospitalized in the digestive cancer surgery and liver transplant service of the IBN ROCHD University Hospital Center in Casablanca. Evaluation from a series of 80 cases of gastric adenocarcinomas, follow-up to determine the prognostic factors influencing mortality, morbidity and survival.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2016

Typical duration for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2016

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2018

Completed
3 years until next milestone

First Submitted

Initial submission to the registry

December 27, 2021

Completed
15 days until next milestone

First Posted

Study publicly available on registry

January 11, 2022

Completed
Last Updated

January 11, 2022

Status Verified

December 1, 2021

Enrollment Period

3 years

First QC Date

December 27, 2021

Last Update Submit

January 10, 2022

Conditions

Gastric CancerMortality of Gastric CancerOverall Survival of Patients With Gastric Cancer

Keywords

gastric cancer mortality, gastric cancer treatment

Outcome Measures

Primary Outcomes (1)

  • Overall survival

    An overall survival of patients treated for gastric cancer

    30 months

Interventions

Total or subtotal gastrectomyPROCEDURE

Gastric resection with digestive continuity according Roux or Bilroth

Also known as: Adjuvent chemotherapy

Eligibility Criteria

Age15 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study enrolled all the patients who underwent gastric resection for gastric adenocarcinoma

You may qualify if:

  • patients with gastric cancer

You may not qualify if:

  • patients with benign tumors or other pathologies requiring gastric resection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Stomach Neoplasms

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesStomach Diseases

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

December 27, 2021

First Posted

January 11, 2022

Study Start

January 1, 2016

Primary Completion

December 31, 2018

Study Completion

December 31, 2018

Last Updated

January 11, 2022

Record last verified: 2021-12